Product Information
ATOVAQUONE 750 MG/5 ML SUSP CUP is a generic product labeled by Kesin Pharma Corporation, priced at $0.7668 per ML under NDC 81033010442. Its NADAC has been published 100 times since Nov 6, 2024.
FDA first approved this application on Mar 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/5mL
Manufacturer
Kesin Pharma CorporationNDC
81033010442
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATOVAQUONEApproval Type
Generic (ANDA)
FDA Application
ANDA212918FDA Approved
3/30/2021
TE Code
AB
On Market Since
6/17/2024
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE 750 MG/5 ML SUSP CUP has been published 100 times since Nov 6, 2024, and over the history we have for it it has declined 19.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7668 per ML |
|---|---|
| All-time high | $0.9555 (Nov 13, 2024) |
| All-time low | $0.6842 (Jul 22, 2026) |
| 52-week high | $0.8766 |
| 52-week low | $0.6842 |
| Median price | $0.8019 |
| Average price | $0.7914 |
| Largest weekly change | -26.9% (Nov 20, 2024) |
| Weeks tracked | 100 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Kesin Pharma Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atovaquone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP CUP?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP CUP, manufactured by Kesin Pharma Corporation, is $0.7668 per ML (NDC 81033010442), effective Sep 30, 2026.
How has the price of ATOVAQUONE 750 MG/5 ML SUSP CUP changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP CUP has declined 19.7%. It has been tracked across 100 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP CUP?
Since Nov 6, 2024, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP CUP has ranged from a low of $0.6842 (Jul 22, 2026) to a high of $0.9555 (Nov 13, 2024), with a median of $0.8019 per ML.
Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP CUP?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATOVAQUONE 750 MG/5 ML SUSPENSION CUP, is $0.7418 per ML — about 3% below ATOVAQUONE 750 MG/5 ML SUSP CUP.
Who manufactures ATOVAQUONE 750 MG/5 ML SUSP CUP?
ATOVAQUONE 750 MG/5 ML SUSP CUP (NDC 81033010442) is labeled by Kesin Pharma Corporation, and CMS classifies it as a generic product.